Recardio

Regenerative Cardiac

  • About Us
    • Profile
    • Management
    • Boards
    • Awards
  • Science
    • Approach
    • Background
    • Therapy
  • Clinical
    • Phase 1
    • Phase 2B AMI
    • PHASE 3 (HEAL-AMI)
    • Phase 2B CHF
  • Partnering
  • Meet us at
  • News Center
  • Careers
Learn how we approach
Regenerative Cardiac
Medicine of Tomorrow

LEARN HOW WE APPROACH REGENERATIVE CARDIAC MEDICINE OF TOMORROW

RECARDIO (REgenerative CARDIOvascular Therapy) is a late clinical-stage life science company focusing on therapies for cardiovascular and other diseases. The company is located in San Francisco, California, and is having its operations in USA and Europe. 

The company’s lead drug candidate, dutogliptin, is a DPP-IV inhibitor that has demonstrated significant effects in activating various chemokines like SDF-1, a protein that is critical for cardiac regeneration resulting in healing cardia tissue after an injury.

After receiving FDA and EMA approval, Recardio is currently initiating its global pivotal Phase 3 clinical program in acute myocardial infarction for market authorization in major markets and will fully develop the therapeutic platform as a regenerative medication for patients with various cardiovascular diseases.

News / Events

Phase 3 Heal-MI Study Published 

July 5, 2023

Closings of Series C Financing Round

May 31, 2023

Recardio at BIO International Convention 2023

May 2, 2023

Read More

Clinical Studies

Recardio’s global and pivotal Phase 3 HEAL-MI study is starting in 2023 and evaluating the clinical outcomes of dutogliptin as an adjunct treatment for patients with acute myocardial infarction.

Read More

Careers

Being located in the US and Europe, we are committed to develop the regenerative therapies of the future. To support our clinical development, we are continuously looking to expand our team.

Read More

  • Contact us
  • Imprint
  • Data Privacy

© Recardio inc. 2023 · All Rights Reserved

Copyright © 2023 · Recardio on Genesis Framework · WordPress · Log in